DifGen Pharmaceuticals

DifGen Pharmaceuticals is a global pharmaceutical company focused on developing, manufacturing, and commercializing complex generic drugs and innovative drug delivery systems. The company specializes in high-barrier-to-entry generics and advanced dosage forms, including transdermal patches, oral films, sterile injectables, and complex ophthalmic products. With two major manufacturing sites in Florida, DifGen operates an FDA-registered facility in Tamarac that enhances its capacity for sterile parenteral and ophthalmic dosage forms. This facility utilizes advanced manufacturing technologies and supports a significant annual capacity of nearly two billion finished dosage units. Additionally, DifGen has a Research & Development Centre of Excellence in India, equipped with cutting-edge technology to support a wide range of pharmaceutical dosage forms. DifGen's mission is to be a trusted partner in healthcare, emphasizing integrity, quality, and commitment. The company aims to provide affordable, life-saving medications primarily manufactured in the United States, serving pharmaceutical companies, healthcare providers, and patients alike.

Pharmaceuticals Hyderabad, India ~126 employees

Work at DifGen Pharmaceuticals in HR or recruiting? Claim this page

Employees
126
+1.6% in the 3 months to Jun 2025
12-month attrition
9.4%
Tech: 0%
H1B filings, FY2025
1
Sponsors visas

Headcount trend

DifGen Pharmaceuticals went from 57 employees in Jul 2023 to 126 in Jun 2025. Jan to Jun 2025: 17 people joined, 2 left.

Headcount data through Jun 2025

Org structure

Headcount by department

Other110
HR4
Operations3
Finance3
Engineering3
Sales3

H-1B sponsorship

H-1B Sponsorship Limited
H-1B Filings by Department
Engineering1

Peer reviews

Worked with someone at DifGen Pharmaceuticals?

Anonymous peer reviews on OffTheRecord

Read or write a review

Hiring now

Similar companies

DifGen Pharmaceuticals FAQ

How many employees does DifGen Pharmaceuticals have?

DifGen Pharmaceuticals has about 126 employees, up 1.6% over the 3 months to Jun 2025.

Does DifGen Pharmaceuticals sponsor H1B visas?

Yes. DifGen Pharmaceuticals filed 1 H1B (LCA) application in FY2025, according to the latest U.S. Department of Labor disclosures. It was for a Engineering role.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.